Abstract The MT-II peptide market in 2025 is driven by its synthetic melanocortin analog composition, targeting tanning and metabolic applications. Research data indicates steady demand growth, fueled by rising aesthetic and wellness trends. Product comparisons highlight variations in purity, formulation, and delivery systems, influencing efficacy and safety. A sourcing guide emphasizes quality verification, regulatory compliance, and supplier transparency. Industry knowledge underscores evolving applications in dermatology and weight management, positioning MT-II as a niche yet expanding segment within the peptide industry.
Target Keyword: mt ii peptide
MT-II peptide, scientifically known as Melanotan II, is a synthetic analog of the naturally occurring melanocortin peptide. It is a cyclic heptapeptide with the amino acid sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2. This specific molecular structure is designed to bind with high affinity to melanocortin receptors, primarily MC1R and MC4R. For B2B buyers in the cosmetic raw material and laboratory research sectors, the core value of MT-II lies in its ability to stimulate melanogenesis and influence metabolic pathways. This product is typically sourced by research institutions, cosmetic formulation labs, and wholesale peptide distributors seeking a high-purity, research-grade compound for non-clinical applications.
The standard MT-II peptide is supplied as a lyophilized white powder. Industry benchmarks require a purity level of ≥98% as determined by HPLC analysis. Lower purity grades can introduce impurities that compromise research outcomes and formulation stability. The molecular weight of MT-II is approximately 1024.18 g/mol, and it is highly soluble in water and saline solutions, making it suitable for various buffer systems used in laboratory settings.
Industry data from 2024 indicates that the global MT-II peptide market is projected to grow at a CAGR of 7.2% through 2030, driven by increasing demand in dermatological research and metabolic studies. The highest purity segment (≥99%) accounts for 35% of total wholesale volume.
The production of MT-II peptide involves solid-phase peptide synthesis (SPPS) using Fmoc chemistry. This method allows for precise control over the amino acid sequence and cyclization process. After synthesis, the crude peptide undergoes cleavage and deprotection before being purified. The manufacturing process is critical for ensuring batch-to-batch consistency, which is a primary concern for B2B clients who require reproducible results in their research or formulations.
The key steps in manufacturing include resin loading, sequential amino acid coupling, cyclization, and final cleavage. The crude product is then purified using preparative Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). This step removes truncated sequences and other synthetic byproducts. Following purification, the peptide is lyophilized to produce a stable powder. The entire process is conducted in controlled environments (ISO 8 cleanrooms) to minimize contamination.
Reputable suppliers provide a Certificate of Analysis (CoA) for each batch, which includes HPLC purity data, mass spectrometry (MS) confirmation, and amino acid analysis. Third-party testing by independent laboratories adds an extra layer of verification. B2B buyers should look for the following certifications and documentation:
MT-II peptide is primarily utilized in two distinct commercial channels: cosmetic formulation research and laboratory-based scientific studies. Understanding these application scenarios helps buyers select the appropriate grade and quantity for their specific needs.
In the cosmetic industry, MT-II is investigated for its potential to stimulate melanin production in topical formulations. Research labs focus on developing stable creams, serums, or lotions that can deliver the peptide effectively. The key challenge here is formulation stability, as peptides are sensitive to pH, temperature, and enzymatic degradation. B2B buyers in this segment require small to medium quantities (1g to 10g) for prototype development and stability testing.
Academic and private research institutions use MT-II for studying melanocortin receptor signaling pathways. Its affinity for MC4R makes it a valuable tool in metabolic research, particularly in studies related to appetite regulation and energy expenditure. These applications demand the highest purity grades (≥99%) and comprehensive documentation for publication-grade research. Typical order sizes range from 5mg to 100mg for in vitro assays.
Large-scale distributors and contract research organizations (CROs) purchase MT-II in bulk quantities (50g to 500g or more). These buyers require consistent quality across multiple batches, competitive pricing, and reliable supply chains. The primary use is for repackaging into smaller research vials or for use in large-scale screening studies. Bulk buyers prioritize suppliers with GMP-compliant facilities and robust quality management systems.
The market contains a wide range of peptide products with varying quality levels. The following comparison table highlights the critical differences between high-grade MT-II and low-grade alternatives, enabling informed purchasing decisions.
| Item | Our Product (High-Grade MT-II) | Alternatives (Low-Grade Peptides) | Advantages |
|---|---|---|---|
| Purity (HPLC) | ≥98% (≥99% premium) | Often <95% with visible impurity peaks | Higher purity ensures reliable research outcomes and fewer side reactions. |
| Endotoxin Level | <1.0 EU/mg | May exceed 5.0 EU/mg | Low endotoxin is critical for in vivo studies and sensitive cell assays. |
| Counterion Content | Acetate or TFA, precisely controlled | Unknown or inconsistent counterion levels | Controlled counterion ensures accurate peptide content and solubility. |
| Documentation | Full CoA, MS, HPLC, stability data | Often missing or incomplete documentation | Complete documentation supports regulatory compliance and research validity. |
| Batch Consistency | CV <5% across batches | High variability between batches | Consistent batches enable reproducible experiments and formulation development. |
Selecting the right MT-II peptide supplier is a critical business decision for B2B buyers. The market includes both reputable manufacturers and opportunistic resellers. A systematic approach to evaluation can mitigate risks and ensure a reliable supply chain.
Buyers often encounter issues such as misrepresented purity, inconsistent batch quality, and lack of proper documentation. Some suppliers may offer significantly lower prices, which often correlates with lower purity or adulterated product. Another common pitfall is insufficient attention to storage and shipping conditions, as peptides are sensitive to temperature fluctuations. Always verify that the supplier uses cold chain shipping for international orders.
High-grade MT-II peptide offers several distinct advantages that justify its selection over lower-quality alternatives. These benefits directly impact research validity, formulation success, and overall cost-effectiveness for B2B buyers.
The primary advantage is guaranteed purity of ≥98% with full HPLC and MS documentation. This purity level minimizes the risk of introducing unknown variables into research protocols. Additionally, the lyophilized powder exhibits excellent stability when stored correctly, with a shelf life of up to 24 months at -20°C. This stability reduces waste and allows for long-term inventory management.
While the upfront cost per gram may be higher than low-grade alternatives, the effective cost is lower due to reduced failure rates and reproducible results. A single failed experiment due to impure peptide can cost more in materials and labor than the price difference. Furthermore, reputable suppliers provide comprehensive technical support, including detailed protocols for reconstitution and handling, which is invaluable for labs new to working with MT-II.
Q: What is the standard purity requirement for MT-II peptide used in cosmetic formulation research?
A: For cosmetic formulation research, a purity of ≥98% is standard. This ensures that the active peptide is the primary component, allowing for accurate dose-response studies and stability testing. Lower purity can introduce impurities that may affect formulation color, odor, or stability.
Q: How should MT-II peptide be stored to maintain its integrity during bulk storage?
A: Lyophilized MT-II peptide should be stored at -20°C in a desiccated environment, protected from light. For long-term bulk storage, it is recommended to aliquot the powder into smaller, airtight vials to minimize freeze-thaw cycles. Reconstituted solutions should be stored at 2-8°C and used within 7 days.
Q: What documentation should I request from a supplier to verify the quality of MT-II peptide?
A: You should request a Certificate of Analysis (CoA) that includes the HPLC chromatogram, mass spectrometry confirmation, amino acid analysis, and endotoxin testing results. Additionally, ask for stability data and, if possible, a certificate of third-party testing from an independent laboratory.